ESR1 Mutations Are Frequent in Newly Diagnosed Metastatic and Loco-Regional Recurrence of Endocrine-Treated Breast Cancer and Carry Worse Prognosis
Breast Cancer Research - United Kingdom
doi 10.1186/s13058-020-1246-5
Full Text
Open PDFAbstract
Available in full text
Date
February 3, 2020
Authors
Publisher
Springer Science and Business Media LLC